Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSC-exo Nasal Spray in Acute Ischemic Stroke
NCT07398612Phase 2Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Jan 2026
- Primary completion
- May 2028
- Modality
- Lipid-based Nanoparticles, Cell Therapies
01
Overview
A Phase 2 trial of human adipose-derived stem cell exosomes in ischemic stroke, sponsored by Shanghai General Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
human adipose-derived stem cell exosomes
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07398612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398612.